These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7451622)

  • 21. High-performance liquid chromatography-mass spectrometry method for determination of anagrelide in human plasma.
    Zhu Z; Gonthier R; Neirinck L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):238-43. PubMed ID: 16005692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of the relative bioavailabilities of two prazosin preparations in patients with essential hypertension].
    Rostock G; Faulhaber HD; Unger P; Homuth V; Prehm C; Günzel R
    Pharmazie; 1985 Apr; 40(4):259-61. PubMed ID: 4011659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-receptor function changes after the first dose of prazosin.
    von Bahr C; Lindström B; Seideman P
    Clin Pharmacol Ther; 1982 Jul; 32(1):41-7. PubMed ID: 6282526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The blood pressure lowering effects of intravenous versus intracerebroventricular prazosin in anaesthetised cats.
    Roach AG; Gomeni R; Mitchard M; Nicolas JP; Cavero I
    Eur J Pharmacol; 1978 Jun; 49(3):271-8. PubMed ID: 658140
    [No Abstract]   [Full Text] [Related]  

  • 25. High-performance liquid chromatographic assay for trimetrexate in human plasma.
    Bullen WW; Chang T; Whitfield LR
    J Chromatogr; 1990 Mar; 526(1):266-72. PubMed ID: 2140367
    [No Abstract]   [Full Text] [Related]  

  • 26. Alpha adrenoceptor blockade with oral prazosin.
    Pitterman AB; Rollins DE; Shen DD; Hurwitz A; Hassanein KM
    Clin Pharmacol Ther; 1981 Feb; 29(2):143-8. PubMed ID: 6109587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a solid-phase extraction high-performance liquid chromatographic assay for doxazosin.
    Jackman GP; Colagrande F; Louis WJ
    J Chromatogr; 1991 May; 566(1):234-8. PubMed ID: 1679435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prazosin alters free and total plasma digoxin levels in dogs.
    Plunkett LM; Gokhale RD; Vallner JJ; Tackett RL
    Am Heart J; 1985 Apr; 109(4):847-51. PubMed ID: 3984839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prazosin kinetics and effectiveness in renal failure.
    Lowenthal DT; Hobbs D; Affrime MB; Twomey TM; Martinez EW; Onesti G
    Clin Pharmacol Ther; 1980 Jun; 27(6):779-83. PubMed ID: 7379445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a high-performance liquid chromatography ultraviolet method for lapatinib quantification in human plasma.
    Escudero-Ortiz V; Pérez-Ruixo JJ; Valenzuela B
    Ther Drug Monit; 2013 Dec; 35(6):796-802. PubMed ID: 23942544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
    Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
    Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatography of the oral anti-asthmatic agent pirquinozol and its active metabolite.
    Kirschbaum J; Gibbs V; Foley J; Perlman S
    J Chromatogr; 1980 Nov; 200():282-7. PubMed ID: 6108966
    [No Abstract]   [Full Text] [Related]  

  • 33. High-performance liquid chromatographic measurement of prazosin and terazosin in biological fluids.
    Bhamra RK; Flanagan RJ; Holt DW
    J Chromatogr; 1986 Jul; 380(1):216-21. PubMed ID: 2875081
    [No Abstract]   [Full Text] [Related]  

  • 34. Open assessment of the effect of prazosin on plasma lipids.
    Havard CW; Khokhar AM; Flax JS
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S238-41. PubMed ID: 6177964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Slow elimination of a prazosin metabolite compared to prazosin kinetics after its intravenous administration to rabbits].
    Piotrovskiĭ VK; Veĭko NN; Golovanova IV; Gus'kova TA; Polievktov MK
    Biull Eksp Biol Med; 1987 Jan; 103(1):73-5. PubMed ID: 3801655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of tiodazosin concentrations in human plasma with a fluorescence high-performance liquid chromatographic method.
    Forgue ST; Van Harken DR; Smyth RD
    J Chromatogr; 1985 Jul; 342(1):221-7. PubMed ID: 4044753
    [No Abstract]   [Full Text] [Related]  

  • 37. Doxazosin determination by high-performance liquid chromatography using fluorescence detection.
    Cowlishaw MG; Sharman JR
    J Chromatogr; 1985 Nov; 344():403-7. PubMed ID: 2935549
    [No Abstract]   [Full Text] [Related]  

  • 38. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
    Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the imidazo quinazoline derivative Ro 13-6438 in biological fluids by high-performance liquid chromatography.
    Haefelfinger P; Hess B
    J Chromatogr; 1984 Jan; 305(1):153-61. PubMed ID: 6549616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of raltitrexed in human plasma by high performance liquid chromatography-electrospray ionization-mass spectrometry.
    Hu J; Ding L; Song Q; Gao Y; Qing S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):147-53. PubMed ID: 17459788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.